Kurimoto R - Search Results

1

Current status of medical oncology in Japan--reality gleaned from a questionnaire sent to designated cancer care hospitals.

Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Sakaida E, Tamura K. Takiguchi Y, et al. Among authors: kurimoto r. Jpn J Clin Oncol. 2014 Jul;44(7):632-40. doi: 10.1093/jjco/hyu059. Epub 2014 May 12. Jpn J Clin Oncol. 2014. PMID: 24821975

2

Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic.

Sakaida E, Sekine I, Iwasawa S, Kurimoto R, Uehara T, Ooka Y, Akanuma N, Tada Y, Imai C, Oku T, Takiguchi Y. Sakaida E, et al. Among authors: kurimoto r. Jpn J Clin Oncol. 2014 Feb;44(2):168-71. doi: 10.1093/jjco/hyt186. Epub 2013 Dec 2. Jpn J Clin Oncol. 2014. PMID: 24302758

3

Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.

Sakaida E, Iwasawa S, Kurimoto R, Ebata T, Imai C, Oku T, Sekine I, Tada Y, Tatsumi K, Takiguchi Y. Sakaida E, et al. Among authors: kurimoto r. Jpn J Clin Oncol. 2016 Apr;46(4):370-7. doi: 10.1093/jjco/hyv203. Epub 2016 Jan 10. Jpn J Clin Oncol. 2016. PMID: 26755829 Free PMC article.

4

Stereotactic radiosurgery for patients with brain metastases.

Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Uehara T. Takiguchi Y, et al. Among authors: kurimoto r. Lancet Oncol. 2014 Jun;15(7):e247-8. doi: 10.1016/S1470-2045(14)70182-2. Lancet Oncol. 2014. PMID: 24872103 No abstract available.

5

Chronic obstructive pulmonary disease as a risk factor for lung cancer.

Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Tatsumi K. Takiguchi Y, et al. Among authors: kurimoto r. World J Clin Oncol. 2014 Oct 10;5(4):660-6. doi: 10.5306/wjco.v5.i4.660. World J Clin Oncol. 2014. PMID: 25300704 Free PMC article. Review.

6

[Monitoring the side effects of cancer chemotherapy].

Kurimoto R, Takiguchi Y. Kurimoto R, et al. Nihon Rinsho. 2015 Feb;73 Suppl 2:102-6. Nihon Rinsho. 2015. PMID: 25831732 Japanese. No abstract available.

7

Prophylactic dexamethasone for radiation-induced bone-pain flare.

Ishiwata T, Iwasawa S, Kurimoto R, Ebata T, Takiguchi Y. Ishiwata T, et al. Among authors: kurimoto r. Lancet Oncol. 2016 Feb;17(2):e39-e40. doi: 10.1016/S1470-2045(15)00622-1. Lancet Oncol. 2016. PMID: 26868344 No abstract available.

8

Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.

Kurimoto R, Iwasawa S, Ebata T, Ishiwata T, Sekine I, Tada Y, Tatsumi K, Koide S, Iwama A, Takiguchi Y. Kurimoto R, et al. Int J Oncol. 2016 May;48(5):1825-36. doi: 10.3892/ijo.2016.3419. Epub 2016 Mar 4. Int J Oncol. 2016. PMID: 26984042 Free PMC article.

9

Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma.

Sakaida E, Ebata T, Iwasawa S, Kurimoto R, Yonemori S, Ota S, Nakatani Y, Sekine I, Takiguchi Y. Sakaida E, et al. Among authors: kurimoto r. Intern Med. 2017;56(5):567-570. doi: 10.2169/internalmedicine.56.7675. Epub 2017 Mar 1. Intern Med. 2017. PMID: 28250307 Free PMC article.

10

Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma.

Kurimoto R, Ebata T, Iwasawa S, Ishiwata T, Tada Y, Tatsumi K, Takiguchi Y. Kurimoto R, et al. Oncol Lett. 2017 Jul;14(1):944-950. doi: 10.3892/ol.2017.6188. Epub 2017 May 17. Oncol Lett. 2017. PMID: 28693256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters